Instil Bio

Filed a patent for "tumor-infiltrating lymphocyte (til) transduction methods" on Wed, June 21, 2023

Filed a patent for "fusion constructs for cell therapy" on Wed, May 24, 2023

Filed a patent for "use of fusion constructs for cd4+ t cell therapy" on Wed, May 24, 2023

Filed a patent for "processing of tumor infiltrating lymphocytes" on Thu, June 23, 2022

Filed a patent for "tumor infiltrating lymphocytes and anti-pd-1 antibody combination therapy for the treatment of cancer" on Thu, June 23, 2022

Filed a patent for "tumor infiltrating lymphocytes and anti-pd-1 antibody combination therapy for the treatment of cancer" on Tue, July 19, 2022

Filed a patent for "use of fusion constructs for il-2 independent t cell therapy" on Thu, July 28, 2022

Filed a patent for "use of fusion constructs for il-2 independent t cell therapy" on Fri, October 14, 2022

Filed a patent for "tumor infiltrating lymphocytes and anti-pd-1 antibody combination therapy for the treatment of cancer" on Mon, November 7, 2022

Filed a patent for "receptors providing targeted costimulation for adoptive cell therapy" on Thu, July 20, 2023

Filed a patent for "use of fusion constructs for il-2 independent t cell therapy" on Wed, March 22, 2023

Filed a patent for "chimeric molecules providing targeted costimulation for adoptive cell therapy" on Thu, October 19, 2023

Filed a patent for "use of fusion constructs for il-2 independent t cell therapy" on Thu, February 22, 2024

Filed a patent for "processing of tumor infiltrating lymphocytes" on Thu, June 20, 2024

Filed a patent for "methods of isolating of tumor infiltrating lymphocytes and use thereof" on Thu, December 21, 2023

Filed a patent for "receptors providing targeted costimulation for adoptive cell therapy" on Thu, November 3, 2022

Filed a patent for "chimeric molecules providing targeted costimulation for adoptive cell therapy" on Thu, February 23, 2023

Filed a patent for "receptors providing targeted costimulation for adoptive cell therapy" on Thu, January 5, 2023